<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Med | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-02T16:20:49+08:00</updated>
  <subtitle>Best Evidence, Best Benefit</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020年11月│失败临床研究TOP5</title>
    <updated>2020-12-02T13:47:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/w-s96H9MjXvPDP6bT8Sy5w</id>
    <link href="https://mp.weixin.qq.com/s/w-s96H9MjXvPDP6bT8Sy5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>晚期NSCLC一线免疫治疗「图鉴」​</title>
    <updated>2020-11-30T12:08:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/EExN1u2TnSZz40fah6pGog</id>
    <link href="https://mp.weixin.qq.com/s/EExN1u2TnSZz40fah6pGog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>3年，10+新药：肝癌药物治疗“风暴”来袭</title>
    <updated>2020-11-27T09:55:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/pZ1lg971eTK2lCC-OBw96g</id>
    <link href="https://mp.weixin.qq.com/s/pZ1lg971eTK2lCC-OBw96g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正确理解临床试验中的风险比（HR）</title>
    <updated>2020-11-25T10:31:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/YxN-sSI0CT3Z0cNSXSOcSw</id>
    <link href="https://mp.weixin.qq.com/s/YxN-sSI0CT3Z0cNSXSOcSw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首个！2020年TMB检测及临床应用专家共识出炉</title>
    <updated>2020-11-23T10:21:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/CHFTM7fZgPmLRg9uv0rM3Q</id>
    <link href="https://mp.weixin.qq.com/s/CHFTM7fZgPmLRg9uv0rM3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“双达组合”，晚期肝癌一线治疗再迎里程碑进展</title>
    <updated>2020-11-22T09:52:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/T1T4YIKZh9EZnMrU1QPikA</id>
    <link href="https://mp.weixin.qq.com/s/T1T4YIKZh9EZnMrU1QPikA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>聚焦ASH 2020：BTKi暗潮涌动</title>
    <updated>2020-11-20T11:39:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/nVW4xH2ncW1ED3laoaLmLA</id>
    <link href="https://mp.weixin.qq.com/s/nVW4xH2ncW1ED3laoaLmLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MSI-H/dMMR晚期实体瘤：各家PD-1/PD-L1表现如何？</title>
    <updated>2020-11-18T10:36:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/GPlvL7kFhVvjuUejgyStEg</id>
    <link href="https://mp.weixin.qq.com/s/GPlvL7kFhVvjuUejgyStEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDK4/6抑制剂角逐早期乳腺癌：阿贝西利为何后来居上？</title>
    <updated>2020-11-16T11:17:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/S6sPluIOJjFD7Xmd8UDPDA</id>
    <link href="https://mp.weixin.qq.com/s/S6sPluIOJjFD7Xmd8UDPDA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ALK抑制剂一线PK，哪个更好？</title>
    <updated>2020-11-13T10:24:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/hNBBxRdtQ60GeNMZZ30spQ</id>
    <link href="https://mp.weixin.qq.com/s/hNBBxRdtQ60GeNMZZ30spQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>